Vaxil Bio Ltd. (TSXV:VXL)

Market Cap	438.24K -5.9%
Revenue (ttm)	n/a
Net Income	379.00K
EPS	0.11
Shares Out	3.98M
PE Ratio	1.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	0.1100
Day's Range	n/a
52-Week Range	0.1000 - 0.2900
Beta	-0.19
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 27, 2026

About Vaxil Bio

Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company is headquartered in Toronto, Canada.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: VXL

Financial Performance

Data Sources: S&P Global Market Intelligence and QUODD

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by QUODD.

Last checked:

Nov 9, 2026

Data Sources Report a data error